PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Malignant Mesothelioma Mortality - United States, 1999-2015.

Abstract Malignant mesothelioma is a neoplasm associated with occupational and environmental inhalation exposure to asbestos* fibers and other elongate mineral particles (EMPs) (1-3). Patients have a median survival of approximately 1 year from the time of diagnosis (1). The latency period from first causative exposure to malignant mesothelioma development typically ranges from 20 to 40 years but can be as long as 71 years (2,3). Hazardous occupational exposures to asbestos fibers and other EMPs have occurred in a variety of industrial operations, including mining and milling, manufacturing, shipbuilding and repair, and construction (3). Current exposures to commercial asbestos in the United States occur predominantly during maintenance operations and remediation of older buildings containing asbestos (3,4). To update information on malignant mesothelioma mortality (5), CDC analyzed annual multiple cause-of-death records(†) for 1999-2015, the most recent years for which complete data are available. During 1999-2015, a total of 45,221 deaths with malignant mesothelioma mentioned on the death certificate as the underlying or contributing cause of death were reported in the United States, increasing from 2,479 deaths in 1999 to 2,597 in 2015 (in the same time period the age-adjusted death rates(§) decreased from 13.96 per million in 1999 to 10.93 in 2015). Malignant mesothelioma deaths increased for persons aged ≥85 years, both sexes, persons of white, black, and Asian or Pacific Islander race, and all ethnic groups. Despite regulatory actions and the decline in use of asbestos the annual number of malignant mesothelioma deaths remains substantial. The continuing occurrence of malignant mesothelioma deaths underscores the need for maintaining measures to prevent exposure to asbestos fibers and other causative EMPs and for ongoing surveillance to monitor temporal trends.
PMID
Related Publications

Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry.

A decade of malignant mesothelioma surveillance in Korea.

Update of potency factors for asbestos-related lung cancer and mesothelioma.

Diseases attributable to asbestos exposure: years of potential life lost, United States, 1999-2010.

Malignant mesothelioma mortality--United States, 1999-2005.

Authors

Mayor MeshTerms
Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 28253224
OWN - NLM
STAT- In-Process
DA  - 20170302
LR  - 20170302
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 66
IP  - 8
DP  - 2017 Mar 03
TI  - Malignant Mesothelioma Mortality - United States, 1999-2015.
PG  - 214-218
LID - 10.15585/mmwr.mm6608a3 [doi]
AB  - Malignant mesothelioma is a neoplasm associated with occupational and
      environmental inhalation exposure to asbestos* fibers and other elongate mineral 
      particles (EMPs) (1-3). Patients have a median survival of approximately 1 year
      from the time of diagnosis (1). The latency period from first causative exposure 
      to malignant mesothelioma development typically ranges from 20 to 40 years but
      can be as long as 71 years (2,3). Hazardous occupational exposures to asbestos
      fibers and other EMPs have occurred in a variety of industrial operations,
      including mining and milling, manufacturing, shipbuilding and repair, and
      construction (3). Current exposures to commercial asbestos in the United States
      occur predominantly during maintenance operations and remediation of older
      buildings containing asbestos (3,4). To update information on malignant
      mesothelioma mortality (5), CDC analyzed annual multiple cause-of-death
      recordsdagger for 1999-2015, the most recent years for which complete data are
      available. During 1999-2015, a total of 45,221 deaths with malignant mesothelioma
      mentioned on the death certificate as the underlying or contributing cause of
      death were reported in the United States, increasing from 2,479 deaths in 1999 to
      2,597 in 2015 (in the same time period the age-adjusted death rates section sign 
      decreased from 13.96 per million in 1999 to 10.93 in 2015). Malignant
      mesothelioma deaths increased for persons aged >/=85 years, both sexes, persons
      of white, black, and Asian or Pacific Islander race, and all ethnic groups.
      Despite regulatory actions and the decline in use of asbestos the annual number
      of malignant mesothelioma deaths remains substantial. The continuing occurrence
      of malignant mesothelioma deaths underscores the need for maintaining measures to
      prevent exposure to asbestos fibers and other causative EMPs and for ongoing
      surveillance to monitor temporal trends.
FAU - Mazurek, Jacek M
AU  - Mazurek JM
FAU - Syamlal, Girija
AU  - Syamlal G
FAU - Wood, John M
AU  - Wood JM
FAU - Hendricks, Scott A
AU  - Hendricks SA
FAU - Weston, Ainsley
AU  - Weston A
LA  - eng
PT  - Journal Article
DEP - 20170303
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
EDAT- 2017/03/03 06:00
MHDA- 2017/03/03 06:00
CRDT- 2017/03/03 06:00
AID - 10.15585/mmwr.mm6608a3 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2017 Mar 3;66(8):214-218. doi: 10.15585/mmwr.mm6608a3.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>